Lithium carbonate (400 mg) Prolonged Release Tablets Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Lithium carbonate (400 mg) Prolonged Release Tablets Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Mood Stabiliser
✓ Pan-India Monopoly PCD
✓ 2 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Lithium carbonate (400 mg) Prolonged Release Tablets Tablet Brand Options (2 options)
Trumac Healthcare manufactures and supplies the following Lithium carbonate (400 mg) Prolonged Release Tablets Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Lithium carbonate (400 mg) Prolonged Release Tablets Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Lithium carbonate (400 mg) Prolonged Release Tablets formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Bipolar disorder (acute mania)
- Bipolar disorder maintenance
- Cyclothymia
- Augmentation in treatment-resistant depression
- Schizoaffective disorder (mood-stabilising adjunct)
Mechanism of Action
Lithium is a mood stabiliser whose mechanism involves multiple actions — inhibition of inositol monophosphatase (depleting inositol/PIP2 signalling), inhibition of glycogen synthase kinase-3 (GSK-3), and modulation of serotonergic and noradrenergic neurotransmission. Therapeutic levels 0.6–1.2 mEq/L; toxic >1.5 mEq/L. Narrow therapeutic index requires regular monitoring.
Dosage & Administration
- Adults: starting 400 mg twice daily, titrate to target serum level 0.6–1.2 mEq/L.
- Monitor 12-hour post-dose level every 5–7 days during titration.
Side Effects
- Tremor (fine), polyuria/polydipsia, weight gain, hypothyroidism (long-term), nephrogenic diabetes insipidus, thyroid dysfunction.
- Toxicity: confusion, ataxia, seizures.
Contraindications
- Severe renal/cardiac/thyroid disease, pregnancy (especially first trimester — Ebstein's anomaly), dehydration, on diuretics/NSAIDs (alter lithium clearance).
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Lithium carbonate (400 mg) Prolonged Release Tablets Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 2 brand options for Lithium carbonate (400 mg) Prolonged Release Tablets Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Lithium carbonate (400 mg) Prolonged Release Tablets Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Lithium carbonate (400 mg) Prolonged Release Tablets Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Lithium carbonate (400 mg) Prolonged Release Tablets Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Lithium carbonate (400 mg) Prolonged Release Tablets Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Lithium carbonate (400 mg) Prolonged Release Tablets Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Lithium carbonate (400 mg) Prolonged Release Tablets Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Lithium carbonate (400 mg) Prolonged Release Tablets Tablet?
MRPs range from ₹900 to ₹1000 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Lithium carbonate (400 mg) Prolonged Release Tablets Tablet?